Malignant complications of coeliac disease
Authors:
- N. BrousseNBN. Brousse
- J.W.R. MeijerJMJ.W.R. Meijer
- 1 June 2005
- journal article
- review article
- Published by Elsevier in Best Practice & Research Clinical Gastroenterology
- Vol. 19 (3) , 401-412
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- A Direct Role for NKG2D/MICA Interaction in Villous Atrophy during Celiac DiseaseImmunity, 2004
- Expression of killer cell inhibitory receptors is restricted to true NK cell lymphomas and a subset of intestinal enteropathy-type T cell lymphomas with a cytotoxic phenotypeJournal of Clinical Pathology, 2001
- Refractory sprue, coeliac disease, and enteropathy-associated T-cell lymphomaThe Lancet, 2000
- Intestinal T‐cell lymphoma probably of CD8αα lymphocyte derivationHistopathology, 2000
- Duodeno-jejunal adenocarcinoma as a first presentation of coeliac disease.Journal of Clinical Pathology, 1996
- MONOCLONAL ANTIBODY (HML-1) REACTIVITY OF T-CELL LYMPHOMASThe Lancet, 1989
- Malignancy in coeliac disease--effect of a gluten free diet.Gut, 1989
- Do vascular addressins mediate tissue specific lymphocyte extravasation?The Journal of Pathology, 1988
- MALIGNANT HISTIOCYTOSIS OF THE INTESTINE: A T-CELL LYMPHOMAThe Lancet, 1985
- INTESTINAL LYMPHOMA ASSOCIATED WITH MALABSORPTIONThe Lancet, 1978